Tritium labelling of buprenorphine, a mixed agonist-antagonist opioid ligand, was performed with a specific activity of 2.35 TBq/mmol (63.6 Ci/mrnol) starting with 15,16-didehydrobuprenorphine. Labels at positions 15 and 16 of the morphine skeleton proved to be sufficiently stable under strong acidi
Synthesis of [16,16,17α-2H3] estradiol and [14α,15,15–2H3] estrone of high isotopic purity
✍ Scribed by Ian J. Massey; Laszlo Tökés
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- French
- Weight
- 410 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The title compounds, each of high isotopic purity, were synthesized as internal standards for the mass spectral quantitation of estradiol and estrone. The [^2^H~3~] estradiol 3 was obtained from estrone (1) by alkaline H/^2^H exchange of the C‐16 protons and LiAl^2^LH~4~ reduction of the C‐17 keto function. The [^2^H~3~] estrone 16 was synthesized by a multistep sequence using deuterioboration of a C‐14 double bond and a three step reductive deuteration of a C‐15 keto function as the key steps for deuterium incorporation.
📜 SIMILAR VOLUMES
## Abstract An improved synthesis of the tritium labelled form of the new pharmacon DIENOGEST is described. The [^14^α,15α‐^3^‐H]DIENOGEST was obtained with a specific activity of 51 Ci/mmol and a radiochemical purity > 98%.
## Abstract Starting with catalytic tritiation of 3‐methoxy‐estra‐1,3,5(10),8,14‐pentaen‐17B‐01 (1) the preparation of 17B‐hydroxy‐[14α,15α ‐^3^H] estra‐4,9‐dien‐3‐one (5) is described. The dienone (5) was obtained with a specific activity of 400 GBq/mmol and a radiochemical purity better than 96%.
## Abstract Mercury(II) oxide oxidation of naltrexone (1a) and naloxone (1b) gave 15,16‐didehydronaltrexone (4a) and 15,16 didehydronaloxone (4b). Subsequent reduction of 4a with tritium gas afforded naltrexone‐15,16‐^3^H~2~ having a‐specific activity of 15.3 Ci/mmole. Subsequent equilibration of 4
## Abstract Oxidation of 5α‐cholest‐8(14)‐ene‐3β,7α,15α‐triol with silver carbonate‐celite gave 5α‐cholest‐8(14)‐ene‐7α,15α‐diol‐3‐one in 88% yield. Treatment of the latter compound with tritiated water under basic conditions gave a labeled product which was reduced with lithium tri‐__tert__‐butoxy
## Abstract The preparation of the tritium labelled fetal metabolite estra‐1, 3, 5 (10)‐3, 15α, 16α, 17β‐tetrol 6,7‐^3^H is described. The material was prepared by oxidation of the tetrol tetraacetate lb to the 6‐keto derivative II. Reduction of the 6‐ketone to the 6‐hydroxy compound III and dehydr